
CPHI Americas 2026
06/2026 – 06/2026
Dedicated to developing and manufacturing complex APIs, peptides and oligonucleotides for customers worldwide, using advanced technology platforms to develop sustainable processes and generate strong IP. With three cGMP manufacturing sites, Aurisco offers APIs across respiratory, cardiovascular, oncology, CNS, hormone and antiviral therapies, and provides CDMO services from research through development, registration and commercial manufacturing.

Aucun commentaire disponible.
Laissez votre note & commentaire